IFP Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$44.8K Buy
916
+181
+25% +$8.86K ﹤0.01% 2098
2025
Q1
$25.1K Buy
735
+160
+28% +$5.47K ﹤0.01% 2205
2024
Q4
$22.8K Buy
575
+348
+153% +$13.8K ﹤0.01% 2188
2024
Q3
$10.7K Buy
227
+52
+30% +$2.44K ﹤0.01% 2396
2024
Q2
$9.45K Hold
175
﹤0.01% 2362
2024
Q1
$11.9K Buy
175
+75
+75% +$5.11K ﹤0.01% 2172
2023
Q4
$6.26K Sell
100
-217
-68% -$13.6K ﹤0.01% 2345
2023
Q3
$14.4K Sell
317
-82
-21% -$3.72K ﹤0.01% 2106
2023
Q2
$22.4K Sell
399
-6
-1% -$337 ﹤0.01% 1946
2023
Q1
$27.2K Sell
405
-371
-48% -$24.9K ﹤0.01% 1884
2022
Q4
$66K Sell
776
-322
-29% -$27.4K ﹤0.01% 2030
2022
Q3
$88K Sell
1,098
-83
-7% -$6.65K ﹤0.01% 1948
2022
Q2
$92K Hold
1,181
﹤0.01% 1736
2022
Q1
$92K Buy
1,181
+411
+53% +$32K ﹤0.01% 1736
2021
Q4
$58K Buy
770
+30
+4% +$2.26K ﹤0.01% 1471
2021
Q3
$83K Sell
740
-83
-10% -$9.31K ﹤0.01% 1326
2021
Q2
$133K Sell
823
-31
-4% -$5.01K ﹤0.01% 1101
2021
Q1
$104K Buy
854
+57
+7% +$6.94K ﹤0.01% 1156
2020
Q4
$121K Sell
797
-24
-3% -$3.64K ﹤0.01% 1041
2020
Q3
$68K Buy
821
+190
+30% +$15.7K ﹤0.01% 1166
2020
Q2
$48K Buy
631
+15
+2% +$1.14K ﹤0.01% 1231
2020
Q1
$27K Buy
616
+500
+431% +$21.9K ﹤0.01% 1363
2019
Q4
$8K Sell
116
-24
-17% -$1.66K ﹤0.01% 2003
2019
Q3
$6K Buy
+140
New +$6K ﹤0.01% 2264
2019
Q1
$1K Sell
40
-680
-94% -$17K ﹤0.01% 2191
2018
Q4
$19K Buy
720
+15
+2% +$396 ﹤0.01% 2134
2018
Q3
$31K Sell
705
-148
-17% -$6.51K ﹤0.01% 2160
2018
Q2
$50K Buy
853
+453
+113% +$26.6K ﹤0.01% 1885
2018
Q1
$9K Hold
400
﹤0.01% 2833
2017
Q4
$9K Buy
+400
New +$9K ﹤0.01% 2830
2016
Q2
Sell
-40
Closed -$1K 3877
2016
Q1
$1K Buy
+40
New +$1K ﹤0.01% 2191